Skip to main content

Table 1 The main characteristics of the UT-SCC cell lines included in the study

From: Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma

Cell line

Sex

Age

Primary tumor site

Grade

T

N

M

Specimen site

Type

Radioresistance, AUC

UT-SCC-2

m

60

floor of mouth

2

4

1

0

floor of mouth

primary

1.8 ± 0.2

UT-SCC-5

m

58

tongue

2

1

1

0

tongue

primary

2.3 ± 0.3

UT-SCC-7

m

67

temporal skin

2

1

0

0

neck

metastasis

2.0 ± 0.2

UT-SCC-8

m

42

supraglottic

1

2

0

0

larynx

primary

1.9 ± 0.1

UT-SCC-9

m

81

glottic

1

2

1

0

neck

metastasis

1.4 ± 0.1

UT-SCC-14

m

25

tongue

2

3

1

0

tongue

primary

1.7 ± 0.3

UT-SCC-16A

f

77

tongue

3

3

0

0

tongue

primary

1.8 ± 0.1

UT-SCC-17

m

65

supraglottic

3

2

0

0

sternum

metastasis

1.8. ± 0.1

UT-SCC-19A

m

44

glottic

2

4

0

0

larynx

primary

1.7 ± 0.1

UT-SCC-20A

f

58

floor of mouth

2

1

0

0

floor of mouth

primary

2.1 ± 0.2

UT-SCC-24A

m

41

tongue

2

2

0

0

tongue

primary

2.6 ± 0.3

UT-SCC-25

m

50

tongue

1

2

0

0

tongue

recidive

 

UT-SCC-30

f

77

tongue

1

3

1

0

tongue

primary

2.0 ± 0.1

UT-SCC-32

m

66

tongue

2

3

0

0

tongue

primary

1.7 ± 0.3

UT-SCC-34

m

63

supraglottic

1

4

0

0

larynx

primary

2.0 ± 0.1

UT-SCC-36

m

46

floor of mouth

3

4

1

0

floor of mouth

primary

2.2 ± 0.2

UT-SCC-45

m

76

floor of mouth

3

3

1

0

floor of mouth

primary

2.0 ± 0.1

UT-SCC-46A

m

62

retromolar gingiva

3

1

0

0

gingiva

primary

1.6 ± 0.1

UT-SCC-47

m

78

floor of mouth

3

2

0

0

floor of mouth

primary

2.0 ± 0.2

UT-SCC-50

m

70

glottic

3

2

0

0

larynx (rT2N0)

recidive

 

UT-SCC-60B

m

59

tonsil

1

4

1

0

neck

metastasis

2.2 ± 0.3

UT-SCC-72

m

50

mandibular gingiva

2

4

2

0

gingiva

primary

2.8 ± 0.2

UT-SCC-74A

m

31

tongue

2

3

1

0

tongue

primary

 

UT-SCC-76A

m

52

tongue

2

3

0

0

tongue

primary

2.5 ± 0.2

UT-SCC-79A

f

80

parotid

2

0

2

0

parotid

metastasis

2.4 ± 0.2

UT-SCC-79B

f

80

parotid

2

0

2

0

neck

metastasis

2.5 ± 0.1